CS Decides 8.34% Dilutive Rights Offering to Raise 1.5 Billion Won for New Product R&D

CS has decided to issue 809,499 new common shares via a third-party allotment rights offering, resulting in approximately 8.34% dilution relative to the current outstanding shares of 9,705,565.
The issue price is set at 1,853 KRW, a 10% discount from the reference price of 2,058 KRW, and shares are allocated to major shareholder Jeong Heung-sik and inside director Kwon Young, subject to a one-year lock-up period.
The total proceeds of 1.5 billion KRW will be used for R&D expenses tied to new product and technology development, with expenditures planned from 2026 through 2028.
[AI Summary]The 8.34% dilutive rights offering decided by CS dilutes existing shareholders but aims to secure growth momentum by investing proceeds in new product R&D. While near-term share price may face pressure, the one-year lock-up mitigates overhang risk.